Key Developments: Genpact Ltd (G.N)

G.N on New York Stock Exchange

17.63USD
30 Jul 2014
Price Change (% chg)

$-0.01 (-0.06%)
Prev Close
$17.64
Open
$17.66
Day's High
$17.72
Day's Low
$17.58
Volume
461,093
Avg. Vol
256,166
52-wk High
$21.25
52-wk Low
$13.69

Search Stocks

Latest Key Developments (Source: Significant Developments)

Genpact Ltd to support Honeywell in Asian Markets
Tuesday, 22 Jul 2014 08:00am EDT 

Genpact Ltd:Enters into multi-year contract to deliver finance and accounting (F&A) services in the South East Asian markets for Honeywell, Fortune 100 diversified technology and manufacturing leader.Genpact provides range of business process services for manufacturing businesses including transformation, technology, analytics and outsourcing - applied to business functions spanning finance to aftermarket services.  Full Article

Genpact Ltd names Edward J. Fitzpatrick as Chief Financial Officer
Friday, 27 Jun 2014 09:00am EDT 

Genpact Ltd:Edward J. Fitzpatrick has been appointed chief financial officer effective July 15.He succeeds Mohit Bhatia.  Full Article

Genpact Ltd completes acquisition of Pharmalink Consulting
Thursday, 29 May 2014 04:05pm EDT 

Genpact Ltd:Says that it has closed its previously announced acquisition of Pharmalink Consulting.Now part of Genpact's growing life sciences vertical, the new business is named Genpact Pharmalink Global Regulatory Affairs.  Full Article

Genpact Ltd reaffirms FY 2014 revenue guidance
Monday, 5 May 2014 04:00pm EDT 

Genpact Ltd:Continues to expect FY 2014 revenues of $2.22 to $2.26 billion.FY 2014 revenue of $2.24 billion - Thomson Reuters I/B/E/S.  Full Article

Genpact Ltd, Oliver Wyman collaborate to expand portfolio of risk management solutions
Thursday, 24 Apr 2014 08:00am EDT 

Genpact Ltd and Oliver Wyman:Announces a collaboration to design and deliver new risk management solutions to the financial services industry.Collaboration will further expand the suite of offerings that each firm currently provides to this sector.  Full Article

Genpact Ltd to acquire Pharmalink Consulting-Business Standard
Thursday, 24 Apr 2014 02:42am EDT 

Genpact Ltd:Plans to acquire Pharmalink Consulting, provider of regulatory services in life sciences, for an undisclosed amount-Business Standard.  Full Article

Genpact to acquire regulatory affairs company in life sciences
Wednesday, 23 Apr 2014 12:29pm EDT 

Genpact Ltd:To acquire Pharmalink Consulting, a global provider of regulatory services to the life sciences industry.Pharmalink's employees based in US, UK, India, Ireland and Puerto Rico will become part of Genpact's Life Sciences vertical.  Full Article

Genpact Ltd partnering with Hillshire Brands to manage finance and accounting processes
Wednesday, 26 Mar 2014 08:00am EDT 

Genpact Ltd:Signs multi-year business process outsourcing (BPO) contract with The Hillshire Brands Company.Will help Hillshire Brands transform and run finance and accounting (F&A) operations including accounts payable, accounts receivable, general accounting, master data, payroll, procurement operations support, and inventory control.  Full Article

Genpact Ltd to repurchase up to $300 mln of common shares through modified dutch auction tender offer
Wednesday, 5 Mar 2014 05:31pm EST 

Genpact Ltd:Intends to purchase up to $300 mln of its common shares through a modified Dutch auction tender offer that it expects to commence on March 6, 2014.Under the terms of the tender offer, Genpact's shareholders will have the opportunity to tender some or all of their shares at a price per share of not less than $16.50 per share and not greater than $18.00 per share.  Full Article

Genpact Ltd gives FY 2014 revenue guidance below analysts' estimates - Conference Call
Thursday, 6 Feb 2014 04:30pm EST 

Genpact Ltd:Says FY 2014 revenue guidance is $2.22 billion to $2.26 billion.FY 2014 revenue of $2.35 billion - Thomson Reuters I/B/E/S.  Full Article

BRIEF-Sanoma to cut 50 jobs in Finland, Netherlands

HELSINKI, May 30 - Sanoma Oyj : * CORRECTED-SANOMA SANOMA OYJ (NOT GENPACT) SAYS MAJOR PART OF ITS

No consensus analysis data available.
Search Stocks